Charles F. Wagner Jr.
At a glance: Charles F. Wagner Jr. is Evp, Co & Fo at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Nov 16, 2026, reported a sale of $8.4M. On file: 0 purchase lines ($0) and 4 sale lines ($19.2M).
Disclosed holdings: about $16.6M of VRTX stock: 31,764 shares reported on their latest Form 4 (filed Nov 16, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Co & Fo at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Charles F. Wagner Jr.'s InsiderPrint
4 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 4 times a year, typically $4.4M a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (4)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Anthony KoblinskiCEO · KRMN · 100% match
- John T. ChambersDirector · BE · 100% match
- Walter J. SchellerCEO · HCC · 100% match
- Jesse K. BrayCEO · RKT · 100% match
- Jonathan LumCOO · CACC · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 16SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 15,28631,764 held (−32%) | $547.87 | $8.4M | -4.8% |
| Jan 8SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 9,53237,725 held (−20%) | $461.00 | $4.4M | +13.1% |
| Dec 5SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 7,00044,725 held (−14%) | $451.00 | $3.2M | +15.6% |
| Dec 5SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 7,00037,725 held (−16%) | $461.00 | $3.2M | +13.1% |
- Sell
Evp, Co & Fo Charles F Wagner Jr. sold $8.4M of VRTX at $547.87 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Co & Fo Charles F Wagner Jr. sold $4.4M of VRTX at $461.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Co & Fo Charles F Wagner Jr. sold $3.2M of VRTX at $451.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Co & Fo Charles F Wagner Jr. sold $3.2M of VRTX at $461.00 — pre-scheduled 10b5-1 plan sale.
Follow Charles F. Wagner Jr.
Get one email when Charles F. Wagner Jr. files a new purchase or sale. Free.
At most one email a day about Charles F. Wagner Jr., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.